CHUGAI PHARMACEUTICAL CO To Go Ex-Dividend On December 27th, 2024 With 0.3608 USD Dividend Per Share

December 25th (Eastern Time) - $CHUGAI PHARMACEUTICAL CO(CHGCF.US)$ is trading ex-dividend on December 27th, 2024.Shareholders of record on December 31st, 2024 will receive 0.3608 USD dividend per

Futu NewsDec 26, 2024 09:00

J.P. Morgan Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Raises Target Price to $56.46

Futu NewsDec 6, 2024 00:31 · Ratings

Macquarie Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Cuts Target Price to $54.85

Futu NewsOct 17, 2024 21:34 · Ratings

Morgan Stanley Initiates CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Announces Target Price $52.54

Morgan Stanley analyst Shinichiro Muraoka initiates coverage on $CHUGAI PHARMACEUTICAL CO(CHGCF.US)$ with a buy rating, and sets the target price at $52.54.According to TipRanks data, the analyst

Futu NewsAug 27, 2024 16:31 · Ratings

J.P. Morgan Initiates CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Announces Target Price $45.6

J.P. Morgan analyst Seiji Wakao initiates coverage on $CHUGAI PHARMACEUTICAL CO(CHGCF.US)$ with a buy rating, and sets the target price at $43.39.According to TipRanks data, the analyst has a

Futu NewsJul 31, 2024 03:32 · Ratings

Jefferies Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Raises Target Price to $46.18

Jefferies analyst Stephen Barker maintains $CHUGAI PHARMACEUTICAL CO(CHGCF.US)$ with a buy rating, and adjusts the target price from $45.58 to $46.23.According to TipRanks data, the analyst has a

Futu NewsJul 26, 2024 16:31 · Ratings